New York, US, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Global Gyroscope Market information by Type, ...
Novartis is buying Gyroscope Therapeutics for up to $1.5 billion, as the Swiss drugmaker looks to bolster its gene therapy roster with the British firm’s treatment for an eye condition that can cause ...
· Agreement reached for Gyroscope Therapeutics to be acquired by Novartis for up to $1.5 billion (£1.1 billion[1]) with an upfront cash payment of $800 million (£604 million) and up to $700 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results